New results achieved with proprietary, patented enzyme show potential to
dramatically lower the cost of large-scale CO2 capture
Trading symbol: CST
Outstanding shares: 50,261,136
<p><location>QUEBEC</location>, <chron>Nov. 25</chron> /CNW Telbec/ - CO2 Solution Inc. ("CO2 Solution" or the "Company") is pleased to announce that it has achieved significant results when applying its patented genetically engineered and thermally optimised '5X' carbonic anhydrase enzyme to CO2 capture with certain carbonate and amine absorbent solutions. In tests with low-energy absorbent solutions, the use of the enzyme increased the CO2 reaction rate by more than 50 fold. These results once again point to the potential of the enzyme to substantially lower the capital and operating costs for carbon capture from coal-fired power plants and other large industrial emitters.</p>
<p>The testing was carried out in collaboration with CO2 Solution's process partner, Procede Group B.V., a leading chemical engineering firm. The Co-Founder of Procede, <person>Dr. Geert Versteeg</person> is also member of CO2 Solution's Scientific Advisory Board. CO2 Solution will utilize these results towards its development of an optimized process for field testing, which it is planning to begin in <location>Canada</location> in 2010.</p>
<p>CO2 Solution is also pleased to announce that it has filed three new patent applications in the field of enzymatic carbon capture which it believes will have significant value by further expanding the range of application of its enzymatic technology in packed columns and other scrubbing systems. Amongst the patent applications, is a new enzyme delivery method which the Company believes will provide for further improvements in utilizing carbonic anhydrase for efficient CO2 capture.</p>
<p>Commenting on the results achieved and the new patent applications, <person>Mr. Glenn Kelly</person>, President & CEO stated: "In an environment where a cost-effective solution for CO2 capture is fundamental to the adoption of CCS technologies, these results show the significant potential for our technology. In line with this work, the new patent applications further secure our position as the leader in the application of carbonic anhydrase, especially given the recent increased level of industry interest surrounding its ability to lower CO2 capture costs."</p>
<p><person>Dr. Geert Versteeg</person>, Co-Founder of Procede Group also commented that "Based on the results, I am very excited about the potential for CO2 Solution's enzymatic technology to outperform other techniques to accelerate the rate of CO2 absorption in carbonates and conventional, lower-energy amines. The technology points to the potential for material capital cost savings for these low-energy solvent processes at a large-scale, which is a significant industry challenge currently".</p>
<p>About CO2 Solution</p>
<p>Based in <location>Quebec</location> City, CO2 Solution Inc. has developed a proprietary bio-technological platform for the efficient capture of carbon dioxide (CO2), the most important greenhouse gas (GHG), from power plants and other large stationary sources of emissions. The Company's technology platform exploits the natural power of a bio-catalyst (enzyme), carbonic anhydrase, which functions within humans and other mammals to manage CO2 during respiration. CO2 Solution has successfully adapted the enzyme to function within an industrial environment, and thus has taken advantage of a biomimetic approach to CO2 capture based on millions of years of evolution. The Company is commercializing its technology for coal fired power generation, the oil sands and other CO2-intensive industries where a low-cost capture solution is key to meeting climate change legislation in a cost effective manner.</p>
<p>CO2 Solution's technology platform is protected by several North American and European patents, including the use of carbonic anhydrase for CO2 capture and release in a packed column system. News releases and additional information can be found at <a href="http://www.co2solution.com">www.co2solution.com</a></p>
The TSX Venture Exchange has neither approved nor disapproved the
information contained herein and accepts no responsibility for it.
For further information: For further information: Annie Chiasson, Director, Corporate Affairs, (418) 842-3456; www.co2solution.com; Source: CO2 Solution Inc.